The market value of Novo Nordisk, the Danish company that makes the weight loss drugs Wegovy and Ozempic, hit $500 billion this past week—a rare achievement for a European firm. Novo Nordisk is owned by a non-profit foundation, which gives the company an unusual corporate structure. Adam and Cameron discuss. Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a>

The market value of Novo Nordisk, the Danish company that makes the weight loss drugs Wegovy and Ozempic, hit $500 billion this past week—a rare achievement for a European firm. Novo Nordisk is owned by a non-profit foundation, which gives the company an unusual corporate structure. Adam and Cameron discuss. Learn more about your ad choices. Visit megaphone.fm/adchoices

The market value of Novo Nordisk, the Danish company that makes the weight loss drugs Wegovy and Ozempic, hit $500 billion this past week—a rare achievement for a European firm. Novo Nordisk is owned by a non-profit foundation, which gives the company an unusual corporate structure. Adam and Cameron discuss. Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices" rel="noopener noreferrer">megaphone.fm/adchoices</a>

The Danish Company Behind Ozempic

Foreign Policy economics columnist Adam Tooze, a history professor and a popular author, is encyclopedic about basically everything: from the COVID shutdown, to climate change, to pasta sauce. On our new podcast, Tooze and FP deputy editor Cameron Abadi will look at two data points each week that explain the world: one drawn from the week’s headlines and the other from just about anywhere else Tooze takes us. Check out Adam Tooze’s column at https://foreignpolicy.com/author/adam-tooze/.

Share The Danish Company Behind Ozempic

Sign up to save your podcasts

The Danish Company Behind Ozempic

The Danish Company Behind Ozempic

More shows like Ones and Tooze

The LRB Podcast

Odd Lots

Foreign Policy Live

Jacobin Radio

Sinica Podcast

The Dig

ChinaTalk

Politics Theory Other

Know Your Enemy

I Spy

Heat of the Moment

The Rachman Review

What's Left of Philosophy

Counterpoint

The Hidden Economics of Remarkable Women (HERO)

The Negotiators

The Foreign Affairs Interview

The Catch

Past Present Future

The Econoclasts

The Economics Show

State of Seed

First Person

The Long Game: Sports Stories of Courage and Conviction

Everyday Ambassador

Editor's Roundtable

Can We End Epidemics?

Foreign Policy Playlist

AVPN: Asian Leadership for an Inclusive World

Munich Moments